NasdaqHealth CareHealth Care ServicesS&P SmallCap 600
$24.42
+0.48 (+2.01%)
Close of Nov 06, 2026 · end-of-day data
PRVA 8-K filings in 2024
Every material Form 8-K Privia Health Group filed with the SEC in 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Privia Health reported third-quarter 2024 results on November 7, 2024, with revenue up 4.9% to $437.9 million and adjusted EBITDA up 25.8% to $23.6 million. GAAP net income fell 37.4% to $3.5 million, and GAAP diluted EPS fell to $0.03 from $0.05. The company raised its full-year 2024 guidance, with all listed metrics now at or above the high end of prior ranges.
Q3 2024 total revenue was $437.9 million, up 4.9% from $417.3 million; GAAP net income was $3.5 million versus $5.6 million a year earlier.
Adjusted EBITDA was $23.6 million, up 25.8%; non-GAAP adjusted net income per diluted share was $0.20 versus $0.17.
Full-year 2024 adjusted EBITDA guidance was raised to $85 million to $90 million, at the high end of the prior range.
Cash and cash equivalents were $422.0 million at September 30, 2024, with no debt.
Privia Health reported second-quarter 2024 results on August 8, 2024, with total revenue of $422.3 million, up 2.2% from a year earlier, while net income attributable to the company fell to $3.5 million from $7.3 million and diluted EPS fell to $0.03 from $0.06. The company also raised its full-year 2024 guidance to the mid-to-high end of its ranges for all metrics, including GAAP revenue of $1,600 million to $1,675 million, so shareholders get higher revenue expectations alongside lower GAAP earnings this quarter.
Q2 2024 total revenue $422.3 million, up 2.2% from $413.4 million; operating income $5.1 million, down 27.0%
Net income attributable to Privia Health $3.5 million, or $0.03 per share, versus $7.3 million, or $0.06, a year earlier
Adjusted EBITDA $22.0 million, up 14.0%; cash and cash equivalents $387.4 million and no debt as of the quarter
FY 2024 guidance raised to mid-to-high end; GAAP revenue guidance $1,600 million to $1,675 million, Adjusted EBITDA $85 million to $90 million
Privia Health Group disclosed that director Bill Sullivan resigned from its Board of Directors and the Board's Audit Committee effective immediately, on July 1, 2024. The company said the resignation was not due to any disagreement on the company's operations, policies, or practices.
Bill Sullivan resigned on July 1, 2024, effective immediately
He left both the Board of Directors and the Audit Committee
The filing states no disagreement with the company on operations, policies, or practices
Privia Health reported first quarter 2024 revenue of $415.2 million, up 7.5% from a year earlier, and reiterated its full-year 2024 guidance. GAAP net income fell to $3.0 million from $7.3 million and operating income fell to $0.8 million from $6.7 million, while non-GAAP adjusted EBITDA rose 18.1% to $19.9 million. Stock-based compensation was $11.9 million, up from $5.4 million, and the company did not change its outlook.
Total revenue was $415.2 million versus $386.3 million in Q1 2023, up 7.5%
Operating income was $0.8 million versus $6.7 million; net income was $3.0 million versus $7.3 million
Non-GAAP adjusted net income rose 16.6% to $22.5 million; adjusted EBITDA rose 18.1% to $19.9 million
Full-year 2024 guidance was reiterated, including GAAP revenue of $1,600 million to $1,675 million and adjusted EBITDA of $85 million to $90 million
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Privia Health Group filing is on SEC EDGAR ↗. 8-K briefs of other companies →